Dr. William W. Wilson Talk 1 on Novel Oral Anticoagulants

Dr. William W. Wilson Talk 2 on Novel Oral Anticoagulants

Heparin | Mechanism of Action, Indications, ADR’s, Contraindications

2012 Patient Seminar: Understanding Anticoagulant Therapy | Jean M. Connors, MD

DVT/PE Diagnosis and Management, Including NOACs - Marc Carrier MD

Anticoagulation & Thrombolytics: Hemostasis - Lesson 6

I have Afib but dont want to take blood thinners!

Direct-Acting Oral Anticoagulants (DOACs) | MOA , Indications, Adverse Reactions, Contraindications

Dr. William W. Wilson Talk 3 on Novel Oral Anticoagulants

Warfarin | Mechanism of Action, Indications, Adverse Reactions, Contraindications

EHRA Free Webinar: Anticoagulation Issues in the Elderly and Patients with CKD & AF

Anticoagulation Strategies for Pulmonary Embolism (KEYNOTE)

Pradaxa and Xarelto: A Case Study in Evidence Based Medicine

DOACs vs Warfarin - WHEN TO USE ONE vs THE OTHER

Dr. Jeffrey Weitz discusses Factor XI/XIa during the 32nd Congress

New Anticoagulants for Stroke Prevention in Atrial Fibrillation | Christian Ruff, MD

Anticoagulation Update (John Eidt, MD)

What You Need to Know about Anticoagulant Therapy Video – Brigham and Women’s Hospital

Heparin - Anticoagulants - Blood Thinner

Anticoagulation Post Stroke: Who, What, When?

Oral Anticoagulants || Warfarin || Rivaroxaban || Apixiban || Dabigatran